cbdMD (YCBD) Inventory-to-Revenue : 0.44 (As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is cbdMD Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. cbdMD's Average Total Inventories for the quarter that ended in Dec. 2024 was $2.24 Mil. cbdMD's Revenue for the three months ended in Dec. 2024 was $5.11 Mil. cbdMD's Inventory-to-Revenue for the quarter that ended in Dec. 2024 was 0.44.

cbdMD's Inventory-to-Revenue for the quarter that ended in Dec. 2024 declined from Sep. 2024 (0.61) to Sep. 2024 (0.44)

A decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. cbdMD's Days Inventory for the three months ended in Dec. 2024 was 119.42.

Inventory Turnover measures how fast the company turns over its inventory within a year. cbdMD's Inventory Turnover for the quarter that ended in Dec. 2024 was 0.76.

cbdMD Inventory-to-Revenue Historical Data

The historical data trend for cbdMD's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

cbdMD Inventory-to-Revenue Chart

cbdMD Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Inventory-to-Revenue

Get a 7-Day Free Trial

0.11

0.13

0.17

cbdMD Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Inventory-to-Revenue	Get a 7-Day Free Trial															0.71	0.80	0.65	0.61	0.44

Competitive Comparison of cbdMD's Inventory-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, cbdMD's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

cbdMD's Inventory-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, cbdMD's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where cbdMD's Inventory-to-Revenue falls into.

Save Embed

;

Save Embed

;

cbdMD Inventory-to-Revenue Calculation

cbdMD's Inventory-to-Revenue for the fiscal year that ended in Sep. 2024 is calculated as

	Inventory-to-Revenue (A: Sep. 2024 )
=	Average Total Inventories					/	Revenue
=	( (Total Inventories (A: Sep. 2023 )	+	Total Inventories (A: Sep. 2024 ))	/	count )	/	Revenue (A: Sep. 2024 )
=	( (4.053	+	2.365)	/	2 )	/	19.482
=	3.209					/	19.482
=	0.16

cbdMD's Inventory-to-Revenue for the quarter that ended in Dec. 2024 is calculated as

	Inventory-to-Revenue (Q: Dec. 2024 )
=	Average Total Inventories					/	Revenue
=	( (Total Inventories (Q: Sep. 2024 )	+	Total Inventories (Q: Dec. 2024 ))	/	count )	/	Revenue (Q: Dec. 2024 )
=	( (2.365	+	2.116)	/	2 )	/	5.113
=	2.2405					/	5.113
=	0.44

cbdMD (AMEX:YCBD) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

cbdMD's Days Inventory for the three months ended in Dec. 2024 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2024 )	/	Cost of Goods Sold (Q: Dec. 2024 )	*	Days in Period
	=	2.2405	/	1.712	*	365 / 4
	=	119.42

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

cbdMD's Inventory Turnover for the quarter that ended in Dec. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Dec. 2024 )	/	Average Total Inventories (Q: Dec. 2024 )
	=	1.712	/	2.2405
	=	0.76

cbdMD Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of cbdMD's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

cbdMD Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » cbdMD Inc (AMEX:YCBD) » Definitions » Inventory-to-Revenue

Comparable Companies

Traded in Other Exchanges

YCBDPA.PFD:USA

Address

2101 Westinghouse Boulevard, Suite A, Charlotte, NC, USA, 28273

Website

https://www.cbdmd.com

cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.

Executives

Thomas Ronan Kennedy	officer: Interim CEO and CFO	8845 RED OAK BLVD, CHARLOTTE NC 28217
Bakari T. Sellers	director	4231 VOORHEES ROAD, DENMARK SC 29042
Raines William F Iii	director	8314 TOSOMOCK LANE, HUNTERSVILLE NC 28078
Scott G. Stephen	director	4249 NORTH WINCHESTER AVE., CHICAGO IL 60613
Sibyl Nichole Swift	director	730 HAWTHORNE LANE, APT 441, CHARLOTTE NC 28204
Kevin Macdermott	officer: President	9580 CALDWELL RD, MOUNT ULLA NC 28125
Wiesehan John J Iii	officer: Chief Revenue Officer	8845 RED OAK BOULEVARD, CHARLOTTE NC 28217
Sim Farar	director	8845 RED OAK BOULEVARD, CHARLOTTE NC 28217
Martin A. Sumichrast	director, officer: Chairman of the Board and CEO	11125 COLONIAL COUNTRY LANE, CHARLOTTE NC 28277
Raymond Scott Coffman	director	230 S. TRYON ST., #1302, CHARLOTTE NC 28202
Peter J. Ghiloni	director	115 DEER ESTATES LANE, PONTE VEDRA BEACH FL 32082
Mark S Elliott	officer: CFO & COO	C/O LEVEL BRANDS, INC., 4521 SHARON ROAD, SUITE 450, CHARLOTTE NC 28211
Gregory C Morris	director	421 CRANBORNE CHASE, FORT MILL SC 29708
Caryn Nicole Dunayer	officer: President	8476 CATAWBA DOVE DR., BELMONT NC 28012
Erik Sterling	10 percent owner	5505 KALANIANAOLE HWY, HONOLULU HI 96821